Health IT

Clearsense unveils its AI strategy at HIMSS 2026, aiming to cut costs and transform passive data archives into active intelligence hubs for healthcare.

AmMetLife appoints veteran actuary Wan Saifulrizal Wan Ismail as CEO. His deep expertise is set to reshape strategy amid rising health costs and new risks.

New disposable encounter-sensing wristbands unveiled at HIMSS 2026 aim to automate clinical documentation, giving valuable time back to patient care.

Dr. Pietro Garbelli's award-winning book offers a crucial roadmap for responsibly integrating AI, balancing high-tech innovation with patient trust.

A new partnership integrates conversational AI with deep EHR analysis, promising to save doctors time, improve diagnoses, and boost hospital revenue.

On its 50th anniversary, NAHQ launches a new ecosystem to arm the healthcare workforce against staff shortages, financial pressures, and digital disruption.

A massive wealth transfer is underway, and traditional financial advisors are losing their grip. Here's how specialized firms are winning this powerful new clientele.

MDClone launches ADAMS Copilot, a GenAI tool letting clinicians analyze data with simple questions, all while keeping sensitive information safe on-site.

Sarah Sommer, a deaf digital marketing exec, joins the Oberkotter Foundation board, blending personal insight with corporate strategy to advance hearing healthcare.

A new study reveals ER burnout isn't just from long hours, but from chaotic patient intake. Can an AI co-pilot be the antidote for exhausted clinicians?

Sword Health expands its Bloom platform, using AI to offer continuous support for women from fertility to menopause and challenge the fragmented healthcare system.

With data from 150M patients, SEQSTER's new platform promises to accelerate drug development, improve trial diversity, and make research-ready data a reality.

A new industry-first model allows health plans to pay only for successful HEDIS gap closures, eliminating financial risk amid rising quality pressures.

A new partnership is pioneering a data-driven family engagement platform, setting a new standard for pediatric health and digital transformation.

A new global survey reveals the crushing mental burden of diabetes, sparking a call for AI-powered tools that promise to restore spontaneity and control.

A NY startup is using quantum computing and AI to fight aging at its source. Can Allosteric Bioscience's high-tech approach unlock a longer, healthier life?

With a unique entry-blocking drug, Bioxytran targets COVID, flu, and RSV, moving toward a pivotal trial that could redefine antiviral treatment.

The national ABA therapy provider is adding center-based care in San Diego and Escondido to meet soaring demand for early intervention services.

With strong revenue growth and critical FDA decisions on the horizon, MannKind's leadership prepares to outline its vision for investors in Miami.

Data shows Achieve Life Sciences' drug helps smokers quit, even after multiple failed attempts with other drugs, as a critical FDA decision looms.